This phenomenon is closely linked to heightened EGFR activity in tumor cells; specifically, activated EGFR signaling can enhance COX-2 transcription and upregulate the production of prostaglandin E2, further amplifying EGFR activity [73,74]. The gene discussed is PTGS2; the disease is neoplasm.